Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > 2 good news: 1- Galbraith (overpaid) is out, good!

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Nov 12, 2020 6:01pm

163 Views

Post# 31887906

RE:2 good news: 1- Galbraith (overpaid) is out, good!

Holy fack! CEO bails! He was new mgmt as you said realstocky? He was the saviour, you said. Losses continue to pile up. They should be well under $5M a month burn or less with this crapp

realstocky wrote:

and... Net loss => $23.3 million for the third quarter of 2020 compared to $29.6 million for the third quarter of 2019, representing a decrease of approximately 22%. WOW!